Research Article

Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease

  1. A. Burns1,
  2. R. Spiegel2,*,
  3. P. Quarg2

Article first published online: 13 FEB 2004

DOI: 10.1002/gps.1058

Issue

International Journal of Geriatric Psychiatry

International Journal of Geriatric Psychiatry

Volume 19, Issue 3, pages 243–249, March 2004

Additional Information

How to Cite

Burns, A., Spiegel, R. and Quarg, P. (2004), Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease. Int. J. Geriat. Psychiatry, 19: 243–249. doi: 10.1002/gps.1058

Author Information

  1. 1

    University of Manchester, Wythenshawe Hospital, Manchester, UK

  2. 2

    Novartis Pharma AG, Basel, Switzerland

*Novartis Pharma AG, Lichtstrasse 35, CH-4002, Basel, Switzerland.

Publication History

  1. Issue published online: 16 FEB 2004
  2. Article first published online: 13 FEB 2004
  3. Manuscript Accepted: 10 NOV 2003
  4. Manuscript Received: 11 FEB 2003

Funded by

  • Novartis Pharma AG, Basel, Switzerland

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (86K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (86K)